Novavax, Inc.
NVAX
$7.95
-$0.43-5.13%
| Weiss Ratings | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.21 | |||
| Price History | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.68% | |||
| 30-Day Total Return | -5.69% | |||
| 60-Day Total Return | -11.67% | |||
| 90-Day Total Return | -12.83% | |||
| Year to Date Total Return | -7.23% | |||
| 1-Year Total Return | 54.67% | |||
| 2-Year Total Return | 32.94% | |||
| 3-Year Total Return | -90.34% | |||
| 5-Year Total Return | -25.35% | |||
| 52-Week High % Change | -64.88% | |||
| 52-Week Low % Change | 119.95% | |||
| Price | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $23.86 | |||
| 52-Week Low Price | $3.81 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Jun 06, 2024 | |||
| Valuation | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.35B | |||
| Enterprise Value | 688.23M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.32 | |||
| Earnings Per Share Growth | -76.09% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.97 | |||
| Price/Book (Q) | -2.15 | |||
| Enterprise Value/Revenue (TTM) | 1.01 | |||
| Price | $7.95 | |||
| Enterprise Value/EBITDA (TTM) | -3.75 | |||
| Enterprise Value/EBIT | -2.97 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 160.24M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 240 268 2000 | |||
| Address | 700 Quince Orchard Road Gaithersburg, MD 20878 | |||
| Website | global.novavax.com | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -33.99% | |||
| Profit Margin | -27.48% | |||
| Management Effectiveness | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -8.63% | |||
| Return on Equity | -- | |||
| Income Statement | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 682.16M | |||
| Total Revenue (TTM) | 682.16M | |||
| Revenue Per Share | $4.26 | |||
| Gross Profit (TTM) | 112.52M | |||
| EBITDA (TTM) | -183.44M | |||
| EBIT (TTM) | -231.93M | |||
| Net Income (TTM) | -187.50M | |||
| Net Income Avl. to Common (TTM) | -187.50M | |||
| Total Revenue Growth (Q YOY) | -69.69% | |||
| Earnings Growth (Q YOY) | 54.58% | |||
| EPS Diluted (TTM) | -1.32 | |||
| EPS Diluted Growth (Q YOY) | 64.94% | |||
| Balance Sheet | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 923.12M | |||
| Cash Per Share (Q) | $5.76 | |||
| Total Current Assets (Q) | 1.13B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -623.84M | |||
| Current Ratio (Q) | 0.978 | |||
| Book Value Per Share (Q) | -$3.89 | |||
| Total Assets (Q) | 1.56B | |||
| Total Current Liabilities (Q) | 1.15B | |||
| Total Debt (Q) | 263.47M | |||
| Total Liabilities (Q) | 2.18B | |||
| Total Common Equity (Q) | -623.84M | |||
| Cash Flow | NVAX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -204.04M | |||
| Cash from Financing (TTM) | 260.58M | |||
| Net Change in Cash (TTM) | -38.52M | |||
| Levered Free Cash Flow (TTM) | -175.64M | |||
| Cash from Operations (TTM) | -87.26M | |||
